Asian Harmonization via Cord Blood Bank Network



Similar documents
The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant

What we will discuss today

Cord Blood Stem Cell Transplantation

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

Corporate Medical Policy Cord Blood as a Source of Stem Cells

ASSEMBLY, No STATE OF NEW JERSEY. 212th LEGISLATURE INTRODUCED FEBRUARY 23, 2006

Umbilical Cord Blood Transplantation

SAVE A LIFE... BY GIVING LIFE!

CORD BLOOD BANKING FAQ

cord blood saves lives...

Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP)

UMBILICAL CORD BLOOD, STEM CELL BANKING

A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD

Not All Stem Cells are the Same

Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science,

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape

A Cure for Sickle Cell Anemia and Thalassemia

The Southeast Asia Data Centre Market A look at new players and key drivers as well as the opportunities and challenges in Asia

Stem Cell Banking. Umbilical Cord. The Leading Cell Bank Protect your family s future

UMBILICAL CORD BLOOD HARVESTING & STORAGE

Corporate Medical Policy Cord Blood as a Source of Stem Cells

PT CordLife Indonesia Premium Cordblood Bank. PT CordLife Indonesia Premium Cordblood Bank

Sepax. your child s cord blood is in safe hands. World leader in adult stem cell processing

Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents

NEWS RELEASE. For Immediate Release. For more information, please contact:

SEARCHING FOR A BONE MARROW DONOR

Overview of Asian Insurance Markets

Phone: Fax:

[Indian Stem Cell Banking Market: Trends & Opportunities ( )]

Directed/Related Cord Blood Collection by NHS Blood and Transplant

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases

Donate your baby s cord blood and save lives.

UMBILICAL CORD BLOOD COLLECTION

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA

House Resolution No. 37

CIGNA HEALTHCARE COVERAGE POSITION

Umbilical Cord Blood Stem Cells Current Status & Future Potential

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION

Cord Blood Market Trends, circa 2014

APPENDIX B SAMPLE INFORMED CONSENT FORM

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine

Connect the Leading Global Financial Centres by Ultra Low Latency Network

STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE

Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.

Transmedcon Ahmedabad, Gujarat November 14-16, 2014

Tax Efficient Supply Chain Management Services

Cord Blood Bank Business Plan

Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa

Cord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program

guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research

Cord Blood Collections for the Texas Cord Blood Bank. Obstetrical Providers Training Module

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT

Collecting cord blood to save and improve lives. Rebecca Roberts

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE

Cord blood donation is a painless and free gesture, helping others and saving lives.

Asian Tigers Mobility

ICT Development Index (IDI)

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points

OneMedForumSF 2012 Conference. January 10th

The essential choice in cell processing

STEM CELL THERAPEUTIC AND RESEARCH ACT OF 2005

Joint General Assembly APLAC-PAC 2014 June 21-28, Guadalaja, Mexico

It s not something you want to think about, but it s something you want to prepare for.

BUSINESS INTELLIGENCE & TARGET MARKETING. Copyright CNCData. All Rights Reserved.

Guideline for staff involvement and responsibility with cord blood collection for stem cells (GL811)

EASTSPRING INVESTMENTS ASIA INVESTOR BEHAVIOUR STUDY 2015 INDONESIA. October eastspring.co.id

OVERVIEW OF CURRENT STATUS OF STEM CELL TRANSPLANTATION IN VIETNAM

WBMT Global Survey. Helen Baldomero Cape Town November Worldwide Network for Blood and Marrow Transplantation

Public Cord Blood Banking at the National Cord Blood Program (NCBP)

Improving Quality in Cellular Therapy with FACT Accreditation. The Foundation for the Accreditation of Cellular Therapy

Pacnet MPLS-Based IP VPN Keeping pace with your growth

Public Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden

Save up to 25% off stem cell banking with Netcells Biosciences

S. 681 IN THE SENATE OF THE UNITED STATES

Cord Blood - Public and Private Cord Blood Banking

Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant. Recipients

A Gift for life. HTA Licence No

9.b. APEC Oil and Gas Security Exercises

Transcription:

Asian Harmonization via Cord Blood Bank Network Introduced by Shigetaka Asano Of Tokyo Cord Blood Bank SCA 200, Seoul Country China Indonesia Philippines Vietnam Japan Thailand Myanmar Korea Malaysia Cambodia Taiwan Laos Hong Kong Singapore Brunei Population X 0 6,273 228 82 79 26 6 7 22 2 22 5 7 0.3 Birthrate 5.9 22.2 27.3 2.2 0.0 6.6 20..8 2,7 33..3 37.8. 2.8 20 5 2 0.8 0.7 0.6 0. 0.3 0.2 0. 0.05 0.0 SCA 200, Seoul 2 20. Deliveries X 0 6 /Year

PUC Collection Banking Clinical Research Basic Research How can the transmission of communicable diseases be prevented? What processing controls are necessary? How can clinical safety and effectiveness be assured? What labeling is necessary, and what kind of promotion is permissible, for proper use of the products? Potential Clinical Benefits for Patients with Intractable Diseases SCA 200, Seoul 3 Cord Blood Cell Transplantation. Lower GVHD incidence/high tolerance HLA mismatches (Acceptance of -2 antigen mismatched HLA units). 2. Large number of potential donors/ethnic balance 3. No risk to donors (mothers and infants) /easy harvest. Low prevalence of infections 5. Quick supply of cord blood units. CBT Frequency BMT PBCT SCA 200, Seoul Years 2

Biotechnology Revolutions allowing: Production of large quantities of growth factors Cellular & Molecular Therapy Separation of specific cells Production of large numbers of human cells outside the body Modification of cell properties, e g by inserting genes into cells Progress in Stem Cell Biology and Genome Sciences The next 0 years should be a very exciting period in the development of this field. SCA 200, Seoul 5 However, there remain scientific, clinical, and regulatory hurdles/problems to be overcome. Low cell recovery, High cost and hard labor, Lack of common methodology, Low utilization rate, Financial difficulties, etc. Our major issues have been on how to organize, to regulate and to practice the on-demand exchange system, so that they can bring the full potential benefits of cell therapy to patients. SCA 200, Seoul 6 3

Newborn Babies Japan CB Bank Network Fresh PUC Tissues BM & PB P CB Foundation Regional Public CB Bank Consortium Research Bank (CERES) Patients National Research Hospital GMP-grade Cells Technical Instruction Research Consignment Supportive Cooperation Department of Cell Processing University Cell Preparation Services TR Supporting Center PUC: placental & umbilical cord, CB: cord blood, P: placenta, BM: bone marrow, PB: peripheral blood SCA 200, Seoul 7 Tokyo Seoul Beijing Taipei Tianjin Organized in 999 HoChiMinh City Bangkok http://www.asiacord.org SCA 200, Seoul 8

Current Status of AsiaCORD City Inventory Transplant Children Adults Beijing 5,300 39 23 6 Tianjin,500 0 7 3 Seoul 3,000 37 Taipei 5,900 3 3 0 Ho Chi Minh,050 0 Bangkok 35 0 Tokyo 5,300 205 88 7 Total 35,365 303 63 0 SCA 200, Seoul 9 Statute and By Laws, Standards SOP: Nov. 200 SCA 200, Seoul 0 5

Mutual Inspection 2.0.200 Beijing 2.02.200 Tianjin 06.28.2002 Tokyo 08.28.2002 Seoul 03..200 Ho Chi Minh City 07.05.200 Taipei SCA 200, Seoul Request for Search ( as of Sep. 2003) Actual Number of Search Request : 30 Countries : China (Hong Kong): 3, Viet Nam: 8, Korea: 2, China:, Taiwan:, USA: 2, unknown : 3. Year : 200: 5, 2002: 8, 2003: 7. Age : 6 month 67 years (mean 5. years, adults: ) Disease : ALL: 6, AML: 6, CML: 8, Thalassemia: 5, JML:, MDS:, NHL:, RAEBt:, X- linked Lymphoproliferative disease:, Aplastic Anemia:, unknown : 3. SCA 200, Seoul 2 6

Exchange of Scientific Information By Tokyo International Symposia on Cord Blood Transplantation Year Subtitle st 996 Current status of cord blood stem cell transplantation 2nd 998 Responding to diversity and information exchange in cord blood banking 3rd 999 Network of cord blood banks worldwide th 2000 Future of cord blood transplantation 5th 200 Placenta/umbilical cord and regenerative biology 6th 2002 Focusing on current issues in cord blood transplantation 7th 2003 Global collaboration and harmonization SCA 200, Seoul 3 AsiaCORD Network : 2005 CB Bank AsiaCORD/NETCORD NETCORD (Tokyo Server) (Düsseldorf Server) AsiaCORD Asia CORD Data & WEB CB Bank CB Bank CB Bank CB Bank Asia CORD Cell Transplantion Center CB Data Data search SCA 200, Seoul 7

http://www.asiacord.org SCA 200, Seoul 5 Co-operative Works in Keeping the Public Cell Bank Activity Obstetricians Basic Scientists Clinical Scientists Citizens Companies Bank Medical Staffs Journalists Government Such cooperation will provide a lot of chances for ethical, legal, and social implication researches and may contribute to establish a public intellectual base for advanced medicine. SCA 200, Seoul 6 8